The subject of the order is the delivery of medicinal products with labelling used in the framework of the non-commercial clinical trial of DIPGen - 2 packages, as defined in the proposed contract provisions in quantities arising from current needs and within dates arising from concluded agreement.

Rapamune 1 mg (Sirolimusum) tabl. irritated, pack 30 pieces. Marketing authorisation No EU/1/01/171/007.

Mekinist 0.5 mg (Trametinibum) tabl. coated, pack 30 pieces. Marketing authorisation No: EU/1/14/931/002.